ARCHIVES

Benefit Seen In Novel Drug That Treats Gleevec Resistance

This article is from The Cancer Letter archive.

Vol. 28 No. 4 | April 29, 2005

Download PDF Visit The Full Archive

Related Articles

Biomira Ends Agreement On Lymphoma Vaccine.

May 4, 2001

Trials Approved by NCI CTEP For the Month of April

April 27, 2012

In Brief: National Patient Advocates Foundation Formed To Seek Health Insurance Reform

November 15, 1996

Clinical Trials Approved By NCI CTEP During May

June 28, 2002

FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March.

January 21, 2005

NCI Barred PI Wolmark And Its Own Prevention Staff From Ad Hod Meeting.

April 20, 2007